Imperial College London

DrJonathanKrell

Faculty of MedicineDepartment of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Krell:2011:10.1016/j.clbc.2011.03.012,
author = {Krell, J and James, CR and Shah, D and Gojis, O and Lim, A and Riddle, P and Ahmad, R and Makris, A and Cowdray, A and Chow, A and Babayev, T and Madden, P and Leonard, R and Cleator, S and Palmieri, C},
doi = {10.1016/j.clbc.2011.03.012},
journal = {CLINICAL BREAST CANCER},
pages = {153--160},
title = {Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome},
url = {http://dx.doi.org/10.1016/j.clbc.2011.03.012},
volume = {11},
year = {2011}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Krell,J
AU - James,CR
AU - Shah,D
AU - Gojis,O
AU - Lim,A
AU - Riddle,P
AU - Ahmad,R
AU - Makris,A
AU - Cowdray,A
AU - Chow,A
AU - Babayev,T
AU - Madden,P
AU - Leonard,R
AU - Cleator,S
AU - Palmieri,C
DO - 10.1016/j.clbc.2011.03.012
EP - 160
PY - 2011///
SN - 1526-8209
SP - 153
TI - Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome
T2 - CLINICAL BREAST CANCER
UR - http://dx.doi.org/10.1016/j.clbc.2011.03.012
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000292477500003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 11
ER -